Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide

Bioconjugate Chemistry

Volumn 11, Issue 3, 2000, Pages 301-305

  Bhorade, Rajeev ^a   Weissleder, Ralph ^a   Nakakoshi, Tsunenori ^a   Moore, Anna ^a   Tung, Ching Hsuan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; MAGNETIC RESONANCE IMAGING; MAMMALS; PARAMAGNETISM; PEPTIDES;

CELLULAR UPTAKE; HIV TAT; IN-VIVO; MACROCYCLICS; MAMMALIAN CELLS; MEMBRANE TRANSLOCATION; MOLECULAR SENSING; MR CONTRAST AGENTS; TAT PEPTIDE; VIVO CELL TRACKING;

CHELATION;

ANIMALIA; MAMMALIA;

EID: 0034117685     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc990168d     Document Type: Article

References (37)

1. Dubowchik, G. M., and Walker, M. A. (1999) Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs. Pharmacol. Ther. 83, 67-123.
2. Reddy, J. A., and Low, P. S. (1998) Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst. 15, 587-627.
3. Marecos, E., Weissleder, R., and Bogdanov, A., Jr. (1998) Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model. Bioconjugate Chem. 9, 184-91.
4. Rojas, M., Donahue, J. P., Tan, Z., and Lin, Y. Z. (1998) Genetic engineering of proteins with cell membrane permeability. Nat. Biotechnol. 16, 370-5.
5. Fernandez, T., and Bayley, H. (1998) Ferrying proteins to the other side. Nat. Biotechnol. 16, 418-20.
6. Cleves, A. E. (1997) Protein transports: the nonclassical ins and outs. Curr. Biol. 7, R318-20.
7. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91, 664-8.
8. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-7.
9. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., and Prochiantz, A. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271, 18188-93.
10. Avrameas, A., Ternynck, T., Nato, F., Buttin, G., and Avrameas, S. (1998) Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc. Natl. Acad. Sci. U.S.A. 95, 5601-6.
11. Phelan, A., Elliott, G., and O'Hare, P. (1998) Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol. 16, 440-3.
12. Elliott, G., and O'Hare, P. (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-33.
13. Sheldon, K., Liu, D., Ferguson, J., and Gariepy, J. (1995) Loligomers: design of de novo peptide-based intracellular vehicles. Proc. Natl. Acad. Sci. U.S.A. 92, 2056-60.
14. Zhang, L., Torgerson, T. R., Liu, X. Y., Timmons, S., Colosia, A. D., Hawiger, J., and Tam, J. P. (1998) Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. Proc. Natl. Acad. Sci. U.S.A. 95, 9184-9.
15. Efthymiadis, A., Briggs, L. J., and Jans, D. A. (1998) The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. J. Biol. Chem. 273, 1623-8.
16. Pepinsky, R. B., Androphy, E. J., Corina, K., Brown, R., and Barsoum, J. (1994) Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its repressor. DNA Cell Biol. 13, 1011-9.
17. Anderson, D. C., Nichols, E., Manger, R., Woodle, D., Barry, M., and Fritzberg, A. R. (1993) Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide. Biochem. Biophys. Res. Commun. 194, 876-84.
18. Bayley, H. (1999) Protein therapy-delivery guaranteed. Nat. Biotechnol. 17, 1066-1067.
19. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., and Becker-Hapak, M., et al. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4, 1449-52.
20. Vocero-Akbani, A. M., Heyden, N. V., Lissy, N. A., Ratner, L., and Dowdy, S. F. (1999) Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med. 5, 29-33.
21. Lin, Y. Z., Yao, S. Y., Veach, R. A., Torgerson, T. R., and Hawiger, J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255-8.
22. Schluesener, H. J. (1996) Protection against experimental nervous system autoimmune diseases by a human immunodeficiency virus-1 Tat peptide-based polyvalent vaccine. J. Neurosci. Res. 46, 258-62.
23. Morris, M. C., Vidai, P., Chaloin, L., Heitz, F., and Divita, G. (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25, 2730-6.
24. Antopolsky, M., Azhayeva, E., Tengvall, U., Auriola, S., Jaaskelainen, I., Ronkko, S., and Honkakoski, P., et al. (1999) Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties. Bioconjugate Chem. 10, 598-606.
25. Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., and Kahl, U., et al. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857-61.
26. Elliott, G., and O'Hare, P. (1999) Intercellular trafficking of VP22-GFP fusion proteins. Gene Ther. 6, 149-51.
27. Zhang, F., Andreassen, P., Fender, P., Geissler, E., Hernandez, J. F., and Chroboczek, J. (1999) A transfecting peptide derived from adenovirus fiber protein. Gene Ther. 6, 171-81.
28. Singh, D., Bisland, S. K., Kawamura, K., and Gariepy, J. (1999) Peptide-based intracellular shuttle able to facilitate gene transfer in mammalian cells. Bioconjugate Chem. 10, 745-54.
29. Josephson, L., Tung, C. H., Moore, A., and Weissleder, R. (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjugate Chem. 10, 186-91.
30. Moats, R. A., Fraser, S. E., and Meade, T. J. (1997) A "smart" magnetic resonance imaging agent that reports on specific enzymatic activity. Angew. Chem., Int. Ed. Engl. 36, 726-8.
31. Li, W. H., Fraser, S. E., and Meade, T. J. (1999) A calcium-sensitive magnetic resonance imaging contrast agent. J. Am. Chem. Soc. 121, 1413-4.
32. Vives, E., Granier, C., Prevot, P., and Lebleu, B. (1997) Structure-activity relationship study of the plasma membrane translocating protential of a short peptide from HIV-1 Tat protein. Lett. Pept. Sci. 4, 429-36.
33. Mann, D. A., and Frankel, A. D. (1991) Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733-9.
34. Schoepf, U., Marecos, E., Melder, R., Jain, R., and Weissleder, R. (1998) Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. BioTechniques 24, 642-651.
35. Lauffer, R. (1996) MRI contrast agents: basic principles. In Clinical magnetic resonance imaging (R. R. Edelman, J. R. Hesselink, and M. B. Zlatkin, Eds.) pp 177-191, WB Sauders, Philadelphia.
36. Tyagi, S., and Kramer, F. R. (1998) Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 14, 303-8.
37. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A., Jr. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-8.